Surface loop 199-204 in blood coagulation factor IX is a cofactor-dependent site involved in macromolecular substrate interaction
- PMID: 10506162
- DOI: 10.1074/jbc.274.41.29087
Surface loop 199-204 in blood coagulation factor IX is a cofactor-dependent site involved in macromolecular substrate interaction
Abstract
In factor IX residues 199-204 encompass one of six surface loops bordering its substrate-binding groove. To investigate the contribution of this loop to human factor IX function, a series of chimeric factor IX variants was constructed, in which residues 199-204 were replaced by the corresponding sequence of factor VII, factor X, or prothrombin. The immunopurified and activated chimeras were indistinguishable from normal factor IXa in hydrolyzing a small synthetic substrate, indicating that this region is not involved in the interaction with substrate residues on the N-terminal side of the scissile bond. In contrast, replacement of loop 199-204 resulted in a 5-25-fold reduction in reactivity toward the macromolecular substrate factor X. This reduction was due to a combination of increased K(m) and reduced k(cat). In the presence of factor VIIIa the impaired reactivity toward factor X was largely restored for all factor IXa variants, resulting in a more pronounced stimulation by factor VIIIa compared with normal factor IXa (3 to 5 x 10(4)-fold versus 5 x 10(3)-fold). Inhibition by antithrombin was only slightly affected for the factor IXa variant with the prothrombin loop sequence, whereas factor IXa variants containing the analogous residues of factor VII or factor X were virtually insensitive to antithrombin inhibition. In the presence of heparin, however, all chimeric factor IXa variants formed complexes with antithrombin. Thus the cofactors heparin and factor VIIIa have in common that they both alleviate the deleterious effects of mutations in the factor IX loop 199-204. Collectively, our data demonstrate that loop 199-204 plays an important role in the interaction of factor IXa with macromolecular substrates.
Similar articles
-
Structural integrity of the gamma-carboxyglutamic acid domain of human blood coagulation factor IXa Is required for its binding to cofactor VIIIa.J Biol Chem. 1996 Feb 16;271(7):3869-76. doi: 10.1074/jbc.271.7.3869. J Biol Chem. 1996. PMID: 8632006
-
The factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparin.Biochemistry. 2005 Mar 8;44(9):3615-25. doi: 10.1021/bi047934a. Biochemistry. 2005. PMID: 15736971
-
High-affinity, specific factor IXa binding to platelets is mediated in part by residues 3-11.Biochemistry. 1994 Oct 11;33(40):12048-55. doi: 10.1021/bi00206a006. Biochemistry. 1994. PMID: 7918424
-
Region of factor IXa protease domain that interacts with factor VIIIa: analysis of select hemophilia B mutants.Thromb Haemost. 1999 Aug;82(2):218-25. Thromb Haemost. 1999. PMID: 10605707 Review.
-
Phosphatidylserine Regulation of Coagulation Proteins Factor IXa and Factor VIIIa.J Membr Biol. 2022 Dec;255(6):733-737. doi: 10.1007/s00232-022-00265-7. Epub 2022 Sep 13. J Membr Biol. 2022. PMID: 36098799 Review.
Cited by
-
Functional role of O-linked and N-linked glycosylation sites present on the activation peptide of factor X.J Thromb Haemost. 2009 Oct;7(10):1696-702. doi: 10.1111/j.1538-7836.2009.03578.x. Epub 2009 Aug 19. J Thromb Haemost. 2009. PMID: 19691479 Free PMC article.
-
Molecular pathogenesis of a novel Met394Thr variant causing hemophilia B.Mol Genet Genomic Med. 2023 May;11(5):e2147. doi: 10.1002/mgg3.2147. Epub 2023 Feb 16. Mol Genet Genomic Med. 2023. PMID: 36795372 Free PMC article.
-
Activated protein C has a regulatory role in factor VIII function.Blood. 2021 May 6;137(18):2532-2543. doi: 10.1182/blood.2020007562. Blood. 2021. PMID: 33512448 Free PMC article.
-
Surface-loop residue Lys316 in blood coagulation Factor IX is a major determinant for Factor X but not antithrombin recognition.Biochem J. 2000 Sep 15;350 Pt 3(Pt 3):701-7. Biochem J. 2000. PMID: 10970782 Free PMC article.
-
Antithrombotic therapy in acute coronary syndrome: how far up the coagulation cascade will we go?Curr Cardiol Rep. 2010 Jul;12(4):315-20. doi: 10.1007/s11886-010-0117-6. Curr Cardiol Rep. 2010. PMID: 20432072 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous